| 000 | 01820ngm a2200385 a 4500 | ||
|---|---|---|---|
| 001 | HST1995_1_2 | ||
| 003 | UkLoHST | ||
| 006 | m c | ||
| 007 | cr|cna|||a|||| | ||
| 007 | vz|czazum | ||
| 008 | 080121s2009 enk|||||||||||s|||v|eng d | ||
| 028 | 5 | 0 |
_a1995 _bHenry Stewart Talks |
| 035 | _a(UkLoHST)1122 | ||
| 035 | _a(UkLU-K)000947294 | ||
| 040 |
_aUkLU-K _beng _cUkLU-K |
||
| 100 | 1 |
_aKim, Tae Won, _u(Asan Medical Center, University of Ulsan, Korea) _4spk |
|
| 245 | 1 | 0 |
_aUGT1A1 polymorphisms and irinotecan toxicity in colorectal cancer patients _h[electronic resource] / _cTae Won Kim. |
| 260 |
_aLondon : _bHenry Stewart Talks, _c2009. |
||
| 300 |
_a1 online resource (1 streaming video file (31 min.) : _bcolor, sound). |
||
| 490 | 1 |
_aCancer therapy : latest thinking in efficacy and toxicity, _x2056-452X |
|
| 500 | _aAnimated audio-visual presentation with synchronized narration. | ||
| 500 | _aTitle from title frames. | ||
| 505 | 0 | _aContents: Irinotecan activity and safety -- Metabolism of Irinotecan -- Structure of UGT1A -- Role of UGT1A1*28 on irinotecan pharmacogenetics -- Role of UGT1A1*6 in Asians -- Genotype-based dosing of irinotecan -- Other candidates: UGT1A enzyme or transporter. | |
| 506 | _aAccess restricted to subscribers. | ||
| 538 | _aMode of access: World Wide Web. | ||
| 650 | 2 |
_aCamptothecin _xanalogs & derivatives. |
|
| 650 | 2 |
_aCamptothecin _xtoxicity. |
|
| 650 | 2 |
_aColorectal Neoplasms _xdrug therapy. |
|
| 650 | 2 |
_aColorectal Neoplasms _xgenetics. |
|
| 650 | 2 |
_aNeoplasms _xcomplications. |
|
| 650 | 2 |
_aNeoplasms _xtherapy. |
|
| 830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pCancer therapy : latest thinking in efficacy and toxicity. |
|
| 856 | 4 | 0 | _uhttps://hstalks.com/bs/1122/ |
| 856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/385/ _3Series |
| 999 |
_c78505 _d78505 |
||